WHO ICTRP trial
Efficacy and safety study of PAXMAN and HairRepro MEDI Alpha for Chemotherapy…
JPRN-UMIN000048637 · Japan Primary Registries Network (JPRN) · Recruiting
Key facts
| Trial ID | JPRN-UMIN000048637 |
|---|---|
| Public title | Efficacy and safety study of PAXMAN and HairRepro MEDI Alpha for Chemotherapy Induced Alopecia for breast cancer |
| Scientific title | Efficacy and safety study of PAXMAN and HairRepro MEDI Alpha for Chemotherapy Induced Alopecia for breast cancer - PAXMAN and HairRepro MEDI Alpha study |
| Primary sponsor | Department of Surgery and Science, Faculty of Medicine,Academic Assembly, University of Toyama |
| Registry | Japan Primary Registries Network (JPRN) |
| Recruitment status | Recruiting |
| Study type | Interventional |
| Phase | Not applicable |
| Countries | Japan |
| Conditions | breast cancer |
| Interventions | Apply HairRepro MEDI Alpha to the scalp and eyebrows twice a day, 4 ml per application. A scalp cooling system (PAXMAN Scalp Cooling System) is applied to the head during chemotherapy, and cooling is performed from 30 minutes before to 90… |
| Registration date | Aug 15, 2022 |
| Target size | 27 |
| Registry page | center6.umin.ac.jp |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: